Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)

Lancaster General Hospital · with Mayo Clinic · NCT06688396

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
150
US sites recruiting
1
Study start
December 4, 2024
Record last updated
January 30, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This is a prospective, single-arm clinical trial in which participants with dilated cardiomyopathy will invite their first degree relatives to undergo mobile cardiac, electrocardiogram screening.

Being studied: Mobile 6L AI-EKG Screening

Conditions: Dilated Cardiomyopathy; Heart Failure; Heart Disease

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria (Proband)

  • Male or female age ≥ 18 years
  • Confirmed diagnosis of non-ischemic DCM determined at the discretion of the treating physician and defined as LVEF ≤ 45% at any time during the clinical course of the patient
  • Must have at least one living adult FDR
  • Able to provide informed consent

Inclusion Criteria (FDR)

  • Male or female age ≥ 18 years who are first-degree relatives of patients with DCM
  • Proband has provided informed consent
  • FDR able to provide informed verbal consent
  • Access to a smartphone or digital tablet with cellular data or Wi-Fi access

Exclusion Criteria (Proband)

  • DCM attributed to any other secondary form of cardiomyopathy per the investigator's determination
  • Proband has previously informed FDR to undergo cardiac screening
  • Ischemic cause of reduced LVEF
  • evidence of myocardial infarction, inducible ischemia or chest pain on stress testing in absence of coronary angiogram to rule out ischemic disease
  • history of acute coronary syndromes (STEMI (ST-Elevation Myocardial Infarction), NSTEMI (Non-ST-Elevation Myocardial Infarction) or unstable angina) revascularization or ≥75% stenosis of either left main or Left Anterior Descending (LAD) or ≥75% stenosis of 2 major epicardial vessels on angiogram
  • Moderate or greater primary valvular abnormality not due to underlying cardiomyopathy
  • Congenital structural heart disease
  • Severe and untreated or untreatable hypertension
  • Cardiomyopathy due to acute or reversible conditions; examples include tachyarrhythmias, thyroid disorders, iron overload
  • Any secondary cause of reduced LVEF such as pregnancy, myocarditis, amyloidosis, sarcoidosis, exposure to toxins including alcohol, substance abuse or chemotherapeutic drug
  • (CPC Participants only) Home address outside of traveling range

Exclusion Criteria (FDR)

  • Previously informed about cardiac screening or has completed cardiac screening by transthoracic echocardiogram (TTE)
  • Previously diagnosed with reduced LVEF
  • (CPC Participants only) Home address outside of traveling range

Recruiting US locations

  • Lancaster General Hospital

    Lancaster, PA 17602

    Site contact: Halle Becker, MPH · 717-544-1777 · Halle.Becker@pennmedicine.upenn.edu

Study contacts (from the official record)

  • Halle Becker, MPH · 717-544-1777 · Halle.Becker@pennmedicine.upenn.edu
  • Jonathan Derr, MBA · 717-544-1777 · Jonathan.Derr@pennmedicine.upenn.edu
All heart & blood pressure studies in Pennsylvania →
Dilated Cardiomyopathy Detection Using AI and Screening With… (NCT06688396) | Bored Studies